Korean Journal of Radiology

  • 제25권3호
  • /
  • Pages.301-313
  • /
  • 2024
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Comparative Efficacy and Safety of Radiofrequency Ablation and Microwave Ablation in the Treatment of Benign Thyroid Nodules: A Systematic Review and Meta-Analysis

  • Hendra Zufry (Department of Internal Medicine, Faculty of Medicine, Universitas Syiah Kuala) ;
  • Timotius Ivan Hariyanto (Faculty of Medicine, Pelita Harapan University)
  • 투고 : 2023.09.12
  • 심사 : 2023.12.29
  • 발행 : 2024.03.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: The current body of evidence lacks clarity regarding the comparative efficacy and safety of radiofrequency ablation (RFA) and microwave ablation (MWA) as minimally invasive treatments for benign thyroid nodules. The primary objective of this study is to clarify these concerns. Materials and Methods: A comprehensive search was conducted using the Cochrane Library, Scopus, Europe PMC, and Medline databases until October 10th, 2023, using a combination of relevant keywords. This study incorporated literature that compared RFA and MWA for benign thyroid nodules. The primary outcome was the volume reduction ratio (VRR) from baseline to follow-up. Secondary outcomes were symptom score, cosmetic score, ablation time, major complications rate, hemorrhage, hoarseness, skin burn, cough, and sympathetic nerve injury. We used Risk of Bias in Non-randomized Studies - of Interventions (ROBINS-I) tool to assess the risk of bias in the included studies. We employed random effects models to analyze the standardized mean difference (SMD) and odds ratio for the presentation of outcomes. Results: Nine studies with 2707 nodules were included. The results of our meta-analysis indicated similar efficacy between RFA and MWA in terms of VRR during the 1 (SMD 0.06; 95% confidence interval [CI]: -0.13 to 0.26; P = 0.52) and 3 (SMD 0.11; 95% CI: -0.03 to 0.25; P = 0.12) months of follow-up. VRR was significantly higher in RFA than in MWA at the 6 (SMD 0.25; 95% CI: 0.06-0.43; P = 0.008) and 12 month of follow-up (SMD 0.38; 95% CI: 0.17 to 0.59; P < 0.001). There were no significant differences between RFA and MWA in symptom scores, cosmetic scores, or the incidence of complications, including hemorrhage, hoarseness, skin burn, cough, and sympathetic nerve injury. Conclusion: RFA showed a higher VRR than MWA at 6 and 12-month follow-ups, with a comparable safety profile.

키워드

참고문헌

  1. Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008;22:901-911
  2. Durante C, Hegedus L, Czarniecka A, Paschke R, Russ G, Schmitt F, et al. 2023 European Thyroid Association clinical practice guidelines for thyroid nodule management. Eur Thyroid J 2023;12:e230067
  3. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The diagnosis and management of thyroid nodules: a review. JAMA 2018;319:914-924
  4. Gharib H, Hegedus L, Pacella CM, Baek JH, Papini E. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab 2013;98:3949-3957
  5. Hegedus L, Frasoldati A, Negro R, Papini E. European Thyroid Association survey on use of minimally invasive techniques for thyroid nodules. Eur Thyroid J 2020;9:194-204
  6. Ding J, Wang D, Zhang W, Xu D, Wang W. Ultrasound-guided radiofrequency and microwave ablation for the management of patients with benign thyroid nodules: systematic review and meta-analysis. Ultrasound Q 2023;39:61-68
  7. He L, Zhao W, Xia Z, Su A, Li Z, Zhu J. Comparative efficacy of different ultrasound-guided ablation for the treatment of benign thyroid nodules: systematic review and network meta-analysis of randomized controlled trials. PLoS One 2021;16:e0243864
  8. Guo DM, Chen Z, Zhai YX, Su HH. Comparison of radiofrequency ablation and microwave ablation for benign thyroid nodules: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2021;95:187-196
  9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71
  10. Park HY, Suh CH, Woo S, Kim PH, Kim KW. Quality reporting of systematic review and meta-analysis according to PRISMA 2020 guidelines: results from recently published papers in the Korean Journal of Radiology. Korean J Radiol 2022;23:355-369
  11. Sterne JA, Hernan MA, Reeves BC, Savovic' J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919
  12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
  13. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135
  14. Cerit MN, Yucel C, Cerit ET, Yalcin MM, Sendur HN, Oktar SO. Comparison of the efficiency of radiofrequency and microwave ablation methods in the treatment of benign thyroid nodules. Acad Radiol 2023;30:2172-2180
  15. Cheng Z, Che Y, Yu S, Wang S, Teng D, Xu H, et al. US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study. Sci Rep 2017;7:9554
  16. Hu K, Wu J, Dong Y, Yan Z, Lu Z, Liu L. Comparison between ultrasound-guided percutaneous radiofrequency and microwave ablation in benign thyroid nodules. J Cancer Res Ther 2019;15:1535-1540
  17. Javadov M, Karatay E, Ugurlu MU. Clinical and functional results of radiofrequency ablation and microwave ablation in patients with benign thyroid nodules. Saudi Med J 2021;42:838-846
  18. Jin H, Fan J, Lu L, Cui M. A propensity score matching study between microwave ablation and radiofrequency ablation in terms of safety and efficacy for benign thyroid nodules treatment. Front Endocrinol (Lausanne) 2021;12:584972
  19. Korkusuz Y, Groner D, Raczynski N, Relin O, Kingeter Y, Grunwald F, et al. Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation and high intensity focused ultrasound equally safe and effective methods? Eur Radiol 2018;28:929-935
  20. Sonmez S, Onder E, Navdar Basaran M, Caliskan H, Topcu Y, Genc S, et al. A comparison of the 2 thermal ablation procedures for the management of benign thyroid nodules. Endokrynol Pol 2023;74:392-397
  21. Vorlander C, David Kohlhase K, Korkusuz Y, Erbelding C, Luboldt W, Baser I, et al. Comparison between microwave ablation and bipolar radiofrequency ablation in benign thyroid nodules: differences in energy transmission, duration of application and applied shots. Int J Hyperthermia 2018;35:216-225
  22. Yue WW, Wang SR, Lu F, Sun LP, Guo LH, Zhang YL, et al. Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study. Endocrine 2017;55:485-495
  23. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 2000;53:207-216
  24. Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med 2003;22:2113-2126
  25. Ahmed M, Brace CL, Lee FT Jr, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology 2011;258:351-369
  26. Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol 2013;16:192-200
  27. Yue W, Wang S, Wang B, Xu Q, Yu S, Yonglin Z, et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur J Radiol 2013;82:e11-e16
  28. Shin JH, Baek JH, Ha EJ, Lee JH. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol 2012;2012:919650
  29. Boccardi V, Marano L. The geriatric surgery: the importance of frailty identification beyond chronological age. Geriatrics (Basel) 2020;5:12
  30. Lin HS, Watts JN, Peel NM, Hubbard RE. Frailty and postoperative outcomes in older surgical patients: a systematic review. BMC Geriatr 2016;16:157
  31. Stabile G, Bertaglia E, Pappone C, Themistoclakis S, Tondo C, Zorzi A, et al. Influence of age and gender on complications of catheter ablation for atrial fibrillation. J Atr Fibrillation 2015;7:1197
  32. Motaghed Z, Chegeni H, Mosadeghkhah A, Azimi Aval M, Gerami R, Ebrahiminik H. Effect of ultrasound parameters of benign thyroid nodules on radiofrequency ablation efficacy. BMC Med Imaging 2023;23:85
  33. Deandrea M, Trimboli P, Mormile A, Cont AT, Milan L, Buffet C, et al. Determining an energy threshold for optimal volume reduction of benign thyroid nodules treated by radiofrequency ablation. Eur Radiol 2021;31:5189-5197
  34. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928
  35. Chorti A, Bontinis V, Tzikos G, Bontinis A, Ioannidis A, Michalopoulos A, et al. Minimally invasive treatments of benign thyroid nodules: a network meta-analysis of short-term outcomes. Thyroid 2023;33:950-964
  36. Pagano L, Durante C, Tufano RP. Editorial: radiofrequency ablation as an alternative to conventional treatment. Front Endocrinol (Lausanne) 2022;13:883809
  37. Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010;21(8 Suppl):S192-S203